phytosphingosine has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beddoes, CM; Bouwstra, JA; Dalgliesh, RM; El Yachioui, D; Gooris, GS; Malfois, M; Nădăban, A; Rissmann, R; Rousel, J | 1 |
| Jung, YG; Kim, BH; Kim, S; Kim, TY; Lee, JM | 1 |
2 other study(ies) available for phytosphingosine and Psoriasis
| Article | Year |
|---|---|
Effect of sphingosine and phytosphingosine ceramide ratio on lipid arrangement and barrier function in skin lipid models.
Topics: Ceramides; Epidermis; Humans; Psoriasis; Skin; Sphingosine | 2023 |
Phytosphingosine derivatives ameliorate skin inflammation by inhibiting NF-κB and JAK/STAT signaling in keratinocytes and mice.
Topics: Adult; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Survival; Dermatitis; Humans; Inflammation; Interleukin-23; Janus Kinase 1; Keratinocytes; Leukocytes, Mononuclear; Male; MAP Kinase Signaling System; Mice; NF-kappa B; Psoriasis; Signal Transduction; Skin; Sphingosine; T-Lymphocytes; Tetradecanoylphorbol Acetate | 2014 |